News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
35,972 Results
Type
Article (2248)
Press Release (33724)
Multimedia
Podcasts (23)
Webinars (2)
Section
Business (11685)
Career Advice (32)
Deals (1667)
Drug Delivery (6)
Drug Development (4315)
Employer Resources (5)
FDA (955)
Job Trends (786)
News (18960)
Policy (1728)
Tag
Academia (198)
Accelerated approval (4)
Adcomms (5)
Allergies (3)
Alliances (2310)
ALS (5)
Alzheimer's disease (69)
Antibody-drug conjugate (ADC) (9)
Approvals (882)
Artificial intelligence (17)
Autoimmune disease (6)
Automation (1)
Bankruptcy (16)
Best Places to Work (644)
BIOSECURE Act (1)
Biosimilars (35)
Bladder cancer (3)
Brain cancer (9)
Breast cancer (17)
Cancer (180)
Cardiovascular disease (16)
Career advice (31)
CAR-T (17)
CDC (44)
Cell therapy (42)
Cervical cancer (1)
Clinical research (3648)
Collaboration (65)
Compensation (7)
Complete response letters (9)
COVID-19 (163)
CRISPR (3)
C-suite (51)
Cystic fibrosis (4)
Data (227)
Depression (13)
Diabetes (22)
Diagnostics (286)
Digital health (2)
Drug discovery (10)
Drug pricing (33)
Drug shortages (2)
Duchenne muscular dystrophy (8)
Earnings (3534)
Editorial (22)
Employer resources (3)
Events (6142)
Executive appointments (58)
FDA (1096)
Funding (78)
Gene editing (6)
Gene therapy (27)
GLP-1 (39)
Government (456)
Grass and pollen (1)
Guidances (16)
Healthcare (1203)
HIV (6)
Huntington's disease (4)
IgA nephropathy (4)
Immunology and inflammation (16)
Immuno-oncology (3)
Indications (2)
Infectious disease (192)
Inflammatory bowel disease (5)
Inflation Reduction Act (3)
Influenza (11)
Intellectual property (5)
Interviews (3)
IPO (698)
IRA (5)
Job creations (172)
Job search strategy (27)
JPM (9)
Kidney cancer (2)
Labor market (4)
Layoffs (43)
Leadership (2)
Legal (428)
Liver cancer (7)
Longevity (2)
Lung cancer (16)
Lymphoma (6)
Management (2)
Manufacturing (38)
MASH (7)
Medical device (515)
Medtech (517)
Mergers & acquisitions (1030)
Metabolic disorders (66)
Multiple sclerosis (8)
Neurodegenerative disease (12)
Neuropsychiatric disorders (6)
Neuroscience (135)
NextGen: Class of 2026 (411)
Non-profit (463)
Obesity (35)
Opinion (15)
Ovarian cancer (17)
Pain (11)
Pancreatic cancer (17)
Parkinson's disease (10)
Partnered (1)
Patents (18)
Patient recruitment (15)
Peanut (2)
People (5255)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (1086)
Phase 2 (1664)
Phase 3 (1122)
Pipeline (196)
Policy (116)
Postmarket research (119)
Preclinical (435)
Prostate cancer (6)
Psychedelics (12)
Radiopharmaceuticals (9)
Rare diseases (46)
Real estate (306)
Recruiting (3)
Regulatory (1177)
Reports (2)
Research institute (179)
Resumes & cover letters (4)
RNA editing (1)
RSV (9)
Schizophrenia (11)
Series A (14)
Series B (8)
Sickle cell disease (5)
Special edition (2)
Spinal muscular atrophy (6)
Startups (296)
Supply chain (7)
Tariffs (27)
The Weekly (22)
Vaccines (165)
Venture capital (9)
Weight loss (21)
Women's health (7)
Worklife (1)
Date
Last 7 days (34)
Last 30 days (109)
Last 365 days (1384)
2026 (141)
2025 (1371)
2024 (1441)
2023 (1864)
2022 (2327)
2021 (2730)
2020 (2573)
2019 (2495)
2018 (2128)
2017 (1786)
2016 (1756)
2015 (2639)
2014 (1663)
2013 (1219)
2012 (1271)
2011 (1213)
2010 (1005)
Location
Africa (15)
Alabama (2)
Arizona (8)
Arkansas (2)
Asia (1061)
Australia (372)
California (350)
Canada (108)
China (13)
Colorado (45)
Connecticut (6)
Delaware (26)
Europe (3932)
Florida (64)
Georgia (11)
Idaho (2)
Illinois (60)
Indiana (20)
Japan (13)
Kansas (10)
Kentucky (4)
Louisiana (1)
Maine (46)
Maryland (111)
Massachusetts (271)
Michigan (9)
Minnesota (16)
Missouri (1)
Nebraska (4)
Nevada (8)
New Jersey (135)
New York (114)
North Carolina (85)
Northern California (160)
Ohio (12)
Oregon (2)
Pennsylvania (127)
Puerto Rico (1)
South America (40)
South Carolina (3)
Southern California (141)
Tennessee (8)
Texas (51)
United States (1565)
Utah (5)
Virginia (13)
Washington D.C. (8)
Washington State (21)
Wisconsin (5)
35,972 Results for "robert bosch".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Methapharm Announces Partnership With Bosch
Methapharm Respiratory, a global leader in respiratory diagnostics, announced a new partnership with Bosch Healthcare Solutions, a wholly owned subsidiary of the Robert Bosch GmbH.
May 21, 2024
·
3 min read
Press Releases
Qlaris Bio Appoints Robert Warner to Board of Directors
January 28, 2026
·
2 min read
Press Releases
PureTech Appoints Robert Lyne as Chief Executive Officer
December 18, 2025
·
5 min read
Press Releases
Robert Stone Recognized as a Top Healthcare CEO in 2025
December 10, 2025
·
4 min read
Press Releases
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
January 5, 2026
·
7 min read
Press Releases
Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer
November 21, 2025
·
2 min read
Press Releases
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
October 23, 2025
·
3 min read
Press Releases
Cumulus Neuroscience Appoints Robert Ballantine to Board of Directors
September 10, 2025
·
3 min read
Press Releases
Pioneering Neurologist and Advocate for Holistic Parkinson’s Care, Bastiaan Bloem, MD, PhD, Receives the Robert A. Pritzker Prize
November 18, 2025
·
5 min read
Earnings
AbbVie’s I&I Portfolio Sells $30 Billion but Execs Again Underline Other Areas
On its fourth quarter earnings call Wednesday, AbbVie CEO Robert Michael called oncology and neuroscience “underappreciated” areas of focus for the pharma.
February 4, 2026
·
2 min read
·
Dan Samorodnitsky
1 of 3,598
Next
